← Leaderboards
Steven E Artandi
Stanford University
$26,596,623
Attributed
$26,596,623
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$59,393,468 · 17
By mechanism
P30$36,288,390 · 3
R01$8,904,695 · 4
R35$6,428,953 · 1
P01$4,309,714 · 4
T32$1,100,776 · 1
RC1$1,000,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Thomas N Robinson$40,790,008
- David Rubenson$2,433,084
- Allan L Reiss$43,607,755
- Craig S Criddle$541,368
- Erik A Sperling$1,599,074
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsMalignant NeoplasmsCellsPathway InteractionsTelomeraseIn VivoSkinTelomereTissuesEngineeringResearch PersonnelDiagnosisStem CellsTumorigenesisCatchment AreaNovel TherapeuticsBasic ScienceEarly DiagnosisCancer CellComplexPopulation SciencesMissionInnovationFunding
Grant awards (93)
Stanford Cancer Institute$4,416,653
P30 · FY2025 · CA · contact PI
Project 2: Immune signals promoting pancreas cancer stemness and progression$423,030
P01 · FY2025 · CA · contact PI
Stanford Cancer Institute$193,000
P30 · FY2025 · CA · contact PI
Leadership, Planning and Evaluation$169,871
P30 · FY2025 · CA · contact PI
Developmental Funds$169,871
P30 · FY2025 · CA · contact PI
Stanford Cancer Institute$94,000
P30 · FY2025 · CA · contact PI
Stanford Cancer Institute$4,223,653
P30 · FY2024 · CA · contact PI
Leadership, Planning and Evaluation$616,942
P30 · FY2024 · CA · contact PI
Developmental Funds$433,659
P30 · FY2024 · CA · contact PI
Project 2: Immune signals promoting pancreas cancer stemness and progression$401,880
P01 · FY2024 · CA · contact PI
Stanford Cancer Institute$171,975
P30 · FY2024 · CA · contact PI
Stanford Cancer Institute$100,000
P30 · FY2024 · CA · contact PI
Stanford Cancer Institute$4,223,653
P30 · FY2023 · CA · contact PI
Leadership, Planning and Evaluation$616,942
P30 · FY2023 · CA · contact PI
Developmental Funds$433,659
P30 · FY2023 · CA · contact PI
Project 2: Immune signals promoting pancreas cancer stemness and progression$414,571
P01 · FY2023 · CA · contact PI
Stanford Cancer Institute$124,999
P30 · FY2023 · CA · contact PI
Stanford Cancer Institute$4,223,653
P30 · FY2022 · CA · contact PI
Leadership, Planning and Evaluation$616,942
P30 · FY2022 · CA · contact PI
Developmental Funds$433,659
P30 · FY2022 · CA · contact PI
Project 2: Immune signals promoting pancreas cancer stemness and progression$414,574
P01 · FY2022 · CA · contact PI
Stanford Cancer Institute$3,334,365
P30 · FY2021 · CA · contact PI
Reversing Cellular immortality in cancer$972,125
R35 · FY2021 · CA · contact PI
Determining the role of TCAB1 in shaping telomerase function$470,088
R01 · FY2021 · AG · contact PI
Stanford Cancer Institute Project HOPE: The Pediatric/AYA Omics Project$119,962
P30 · FY2021 · CA · contact PI
Stanford Cancer Institute$3,334,464
P30 · FY2020 · CA · contact PI
Reversing Cellular immortality in cancer$962,915
R35 · FY2020 · CA · contact PI
Determining the role of TCAB1 in shaping telomerase function$463,270
R01 · FY2020 · AG · contact PI
Stanford Cancer Institute$200,000
P30 · FY2020 · CA · contact PI
Stanford Cancer Institute$28,481
P30 · FY2020 · CA · contact PI
Stanford Cancer Institute$3,324,271
P30 · FY2019 · CA · contact PI
Reversing Cellular immortality in cancer$933,706
R35 · FY2019 · CA · contact PI
Stanford Cancer Institute$500,000
P30 · FY2019 · CA · contact PI
Determining the role of TCAB1 in shaping telomerase function$457,816
R01 · FY2019 · AG · contact PI
Stanford Cancer Institute$243,465
P30 · FY2019 · CA · contact PI
Stanford Cancer Institute$185,749
P30 · FY2019 · CA · contact PI
Stanford Cancer Institute$3,334,464
P30 · FY2018 · CA · contact PI
Reversing Cellular immortality in cancer$962,915
R35 · FY2018 · CA · contact PI
Determining the role of TCAB1 in shaping telomerase function$452,952
R01 · FY2018 · AG · contact PI
Stanford Cancer Institute$248,520
P30 · FY2018 · CA · contact PI
Program in Translational and Experimental Hematology$190,552
T32 · FY2018 · HL · contact PI
Stanford Cancer Institute$171,518
P30 · FY2018 · CA · contact PI
Reversing Cellular immortality in cancer$962,884
R35 · FY2017 · CA · contact PI
Determining the role of TCAB1 in shaping telomerase function$448,326
R01 · FY2017 · AG · contact PI
Program in Translational and Experimental Hematology$204,089
T32 · FY2017 · HL · contact PI
Reversing Cellular immortality in cancer$972,569
R35 · FY2016 · CA · contact PI
Defining the telomerase holoenzyme in progenitor cells with aging$596,753
R56 · FY2016 · AG · contact PI
Program in Translational and Experimental Hematology$287,928
T32 · FY2016 · HL · contact PI
Reversing Cellular immortality in cancer$18,652
R35 · FY2016 · CA · contact PI
REVERSING CELLULAR IMMORTALITY IN CANCER$10,658
R35 · FY2016 · CA · contact PI
Reversing Cellular immortality in cancer$632,529
R35 · FY2015 · CA · contact PI
Understanding telomerase and Wnt signaling in stem cell aging$322,520
P01 · FY2015 · AG · contact PI
Telomeres, Telomerase and Tumor Progression$303,040
R01 · FY2015 · CA · contact PI
Program in Translational and Experimental Hematology$278,839
T32 · FY2015 · HL · contact PI
Regulation of the Telomerase Protein Component In Cancer$273,398
R01 · FY2015 · CA · contact PI
Mouse Aging Core$233,695
P01 · FY2015 · AG · contact PI
Understanding telomerase and Wnt signaling in stem cell aging$332,098
P01 · FY2014 · AG · contact PI
Defining the telomerase holoenzyme in progenitor cells with aging$323,034
R01 · FY2014 · AG · contact PI
Telomeres, Telomerase and Tumor Progression$293,949
R01 · FY2014 · CA · contact PI
Regulation of the Telomerase Protein Component In Cancer$264,953
R01 · FY2014 · CA · contact PI
Mouse Aging Core$241,807
P01 · FY2014 · AG · contact PI
Program in Translational and Experimental Hematology$139,368
T32 · FY2014 · HL · contact PI
Understanding telomerase and Wnt signaling in stem cell aging$316,653
P01 · FY2013 · AG · contact PI
Defining the telomerase holoenzyme in progenitor cells with aging$304,985
R01 · FY2013 · AG · contact PI
Telomeres, Telomerase and Tumor Progression$284,858
R01 · FY2013 · CA · contact PI
Regulation of the Telomerase Protein Component In Cancer$272,953
R01 · FY2013 · CA · contact PI
Mouse Aging Core$227,618
P01 · FY2013 · AG · contact PI
Understanding telomerase and Wnt signaling in stem cell aging$331,347
P01 · FY2012 · AG · contact PI
Defining the telomerase holoenzyme in progenitor cells with aging$322,448
R01 · FY2012 · AG · contact PI
Telomeres, Telomerase and Tumor Progression$303,040
R01 · FY2012 · CA · contact PI
Mouse Aging Core$243,545
P01 · FY2012 · AG · contact PI
Defining the telomerase holoenzyme in progenitor cells with aging$322,172
R01 · FY2011 · AG · contact PI
Understanding telomerase and Wnt signaling in stem cell aging$246,485
P01 · FY2011 · AG · contact PI
Mouse Aging Core$159,891
P01 · FY2011 · AG · contact PI
Studying a Human Stem Cell Disease Using iPS Technology$1,000,000
RC1 · FY2010 · HL · contact PI
Defining the telomerase holoenzyme in progenitor cells with aging$334,900
R01 · FY2010 · AG · contact PI
Regulation of the Telomerase Protein Component In Cancer$276,183
R01 · FY2010 · CA · contact PI
Telomeres, Telomerase and Tumor Progression$294,015
R01 · FY2009 · CA · contact PI
Regulation of the Telomerase Protein Component In Cancer$275,999
R01 · FY2009 · CA · contact PI
Telomeres, Telomerase and Tumor Progression$95,000
R01 · FY2009 · CA · contact PI
Telomeres, Telomerase and Tumor Progression$328,430
R01 · FY2008 · CA · contact PI
Regulation of the Telomerase Protein Component In Cancer$275,825
R01 · FY2008 · CA · contact PI
Telomeres, Telomerase and Tumor Progression$293,771
R01 · FY2007 · CA · contact PI
Regulation of the Telomerase Protein Component In Cancer$275,492
R01 · FY2007 · CA · contact PI
Telomeres, Telomerase and Tumor Progerssion$302,427
R01 · FY2006 · CA · contact PI
Regulation of the Telomerase Protein Component In Cancer$281,649
R01 · FY2006 · CA · contact PI
Telomeres, Telomerase and Tumor Progerssion$309,722
R01 · FY2005 · CA
TELOMERE DYSFUNCTION, GENOMIC INSTABILITY AND CANCER$132,857
K08 · FY2005 · CA
Novel Functions for Telomerase Enzyme Complex in Vivo$100,000
R55 · FY2005 · CA
TELOMERE DYSFUNCTION, GENOMIC INSTABILITY AND CANCER$132,857
K08 · FY2004 · CA
TELOMERE DYSFUNCTION, GENOMIC INSTABILITY AND CANCER$132,857
K08 · FY2003 · CA
TELOMERE DYSFUNCTION, GENOMIC INSTABILITY AND CANCER$132,857
K08 · FY2002 · CA
TELOMERE DYSFUNCTION, GENOMIC INSTABILITY AND CANCER$132,759
K08 · FY2000 · CA